Verastem, Inc. Files 2024 Annual Report
Ticker: VSTM · Form: 10-K · Filed: Mar 20, 2025 · CIK: 1526119
| Field | Detail |
|---|---|
| Company | Verastem, INC. (VSTM) |
| Form Type | 10-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, financials
TL;DR
Verastem's 2024 10-K is in. Check financials and strategy.
AI Summary
Verastem, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, incorporated in Delaware, is in the pharmaceutical preparations industry and is headquartered in Needham, MA. Key financial details and operational aspects for the period are presented in this filing.
Why It Matters
This filing provides a comprehensive overview of Verastem's financial health and strategic direction for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Verastem faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- $1.2M — Deferred Revenue (Represents revenue recognized in advance, impacting future revenue streams.)
- $44.78M — Grants Receivable Net (Indicates funds expected from grants, a potential source of income.)
- $25.28M — Deferred Revenue Current (Short-term portion of deferred revenue, relevant for near-term cash flow.)
Key Players & Entities
- Verastem, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- Needham, MA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- 001-35403 (company_id) — SEC File Number
FAQ
What were Verastem's total revenues for the fiscal year ended December 31, 2024?
The filing does not explicitly state total revenues in the provided snippet, but it does list key financial figures like Grants Receivable Net ($44.78M) and Deferred Revenue ($1.2M).
What is Verastem's primary business activity?
Verastem, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code 2834.
When was Verastem, Inc. incorporated and where is it headquartered?
Verastem, Inc. was incorporated in Delaware and is headquartered at 117 Kendrick Street, Suite 500, Needham, MA 02494.
What significant corporate actions or agreements are mentioned in the filing dates?
The filing mentions dates related to Underwriting Agreements (June 15, 2023, and January 1, 2024), a July 2024 Public Offering (December 23, 2024), and a Certificate of Amendment (May 30, 2023).
What is the SEC file number for Verastem, Inc.'s 10-K filing?
The SEC file number for Verastem, Inc. is 001-35403.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 20, 2025 regarding Verastem, Inc. (VSTM).